Introduction Semaglutide 2.4 mg is the reference pharmacotherapy for weight management, yet many patients do not reach ambitious weight-loss targets. CagriSema, a fixed-dose combination of cagrilintide and semaglutide, may offer additional benefit through complementary mechanisms. We quantified its incremental efficacy...
Zehra Khatoon Rasool, Rajvi K. Shah, Ansharah E. Zinnia Batool et al.· Frontiers in Endocrinology· 0 citations
BBMs play a crucial role in combating Alzheimer’s disease and should be prioritized, it is essential for governments and health organizations to finance evaluations in varied demographics, establish coverage policies, and integrate BBMs into existing workflows.
Muneeb Khawar, Pugazhandhi Bakthavatchalam· Nepal Journal of Epidemiolog...· 0 citations
Restoration of microglial lysosomal acidification represents a promising therapeutic strategy for neurodegenerative diseases and a prognostic biomarker for disease progression and therapeutic response.
R. Jaganathan, Srilakshmi Vijayakumar, Yinchi Chen et al.· Neurobiology of Disease· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.